General Catalyst

Activity from announced rounds

Activity in this selectionUnited States · May 31, 2026 · May 1, 2026

General Catalyst backs companies from formation and seed through growth, and also creates businesses with founders through its Creation strategy.

Creation includes starting companies in complex or emerging industries, helping experienced founders launch again and combining existing service businesses with applied AI. That makes GC relevant both to founders raising for an established startup and to entrepreneurs developing a new company with an investment partner.

For businesses that have reached product-market fit, its Customer Value Fund provides a separate way to finance customer acquisition. This sits alongside seed and growth equity, giving the firm a financing model directed specifically at the cost of expanding a customer base.

Sources
Rounds participated in
7
Confirmed lead rounds
—
7 roles undisclosed
New companies
7
First participation on record · 0 follow-on
Funding in participating rounds
$1.3B
7 disclosed · full round size, not this investor’s share

By stage

Seed3
Series A2
Growth1
Undisclosed1

By primary sector

AI4
Biotech1
Fintech1
Healthtech1

By country

United States7

Rounds

7 in this selection
Cognition

Cognition develops Devin, an autonomous software-engineering system, and the Windsurf AI code editor.

$1BGrowth
Role not disclosed
Status AI

Builds a gamified social simulation platform where users roleplay characters inside AI-generated social worlds

$17MSeries A
Role not disclosed
Forus

Connects healthcare providers, pharmacies, payers and biopharma through AI-assisted treatment-access workflows.

$160MSeries A
Role not disclosed
Greenboard

Provides AI-native platform for securities compliance in financial institutions

$20MUndisclosed
Role not disclosed
Ciridae

Builds AI operating systems for mid-market businesses in logistics, restoration, and industrial services

$20MSeed
Role not disclosed
ParcelBio

Develops potent and durable mRNA medicines using the APEXm platform for autoimmune and oncology

$13MSeed
Role not disclosed
Nace.AI

Provides AI-powered execution of enterprise workflows with human validation

$21.5MSeed
Role not disclosed